Prolotherapy vs. PRP in NYC: Understanding the Differences and Which Is Right for You
Two Regenerative Injection Therapies — One Decision
Patients researching non-surgical options for joint pain, tendon injuries, or ligament laxity frequently encounter both prolotherapy and platelet-rich plasma (PRP) therapy. Both are regenerative injection approaches — both aim to stimulate the body's own healing biology. But they work through different mechanisms, have different evidence profiles, and are appropriate for different clinical presentations.
At Regen Health Physicians NYC, Dr. Ajit Dhaliwal selects between these therapies — and sometimes combines them — based on each patient's specific pathology, history, and goals.
What Is Prolotherapy?
Prolotherapy (short for "proliferative therapy") has been used in clinical practice since the 1930s. It involves injecting an irritant solution — most commonly dextrose (sugar water) at concentrations of 12–25% — into painful ligaments, tendons, or joint spaces.
How Prolotherapy Works
The injected dextrose creates a localized inflammatory response. This inflammation triggers the body to initiate tissue repair, recruiting fibroblasts and stimulating collagen synthesis in the treated area. In chronic conditions where the normal healing cascade has stalled or failed, prolotherapy effectively "re-boots" the healing process.
Clinical applications include:
- Ligament laxity (particularly in the spine, SI joints, and ankles)
- Chronic tendinopathy (Achilles, patellar, tennis elbow)
- Osteoarthritis (early-to-moderate)
- Sacroiliac joint dysfunction
- Chronic low back pain of ligamentous origin
Evidence for Prolotherapy
Prolotherapy has a meaningful evidence base, particularly for low back pain and knee osteoarthritis. A 2016 Cochrane Review found low-quality to moderate-quality evidence supporting prolotherapy for chronic low back pain over injection controls. Multiple RCTs support its use in knee OA.
What Is PRP Therapy?
Platelet-rich plasma therapy uses a different biological strategy. A sample of the patient's own blood is centrifuged to produce a concentrate rich in platelets and growth factors, then injected into the injury site.
How PRP Works
PRP does not rely on a pain-irritant mechanism. Instead, it delivers a concentrated payload of the body's own healing proteins — PDGF, TGF-β, VEGF, EGF, FGF — directly to the tissue in need. These growth factors:
- Stimulate tenocyte and fibroblast proliferation
- Recruit stem cells to the injury site
- Modulate inflammation toward a resolving, healing phenotype
- Improve synovial fluid quality in joints
Evidence for PRP
The PRP evidence base has grown substantially in recent years. Strong evidence exists for:
- Knee osteoarthritis: Multiple meta-analyses confirm PRP superior to corticosteroids and hyaluronic acid at 12 months
- Tennis elbow (lateral epicondylitis): A landmark JAMA study confirmed PRP superior to corticosteroid injection at 1 year
- Rotator cuff tendinopathy: Good evidence for partial tears and chronic tendinopathy
- Patellar tendinopathy: Multiple RCTs confirm meaningful improvement
Prolotherapy vs. PRP: Key Differences
| Feature | Prolotherapy | PRP | |---------|-------------|-----| | Mechanism | Irritant-induced inflammation → collagen synthesis | Growth factor delivery → direct tissue repair | | Active ingredient | Dextrose solution | Patient's own platelets/growth factors | | Evidence strength | Strong for ligament laxity, back pain | Strong for tendons, joints, OA | | Cost | Generally lower per session | Higher per session | | Sessions needed | Often 3–6+ series | Often 1–3 series | | Best for | Ligament laxity, back pain, SI joint | Tendinopathy, OA, acute partial tears |
How RHPNY Selects Between Therapies
There is no universally "better" therapy — context determines appropriateness. At RHPNY, Dr. Dhaliwal applies the following clinical logic:
PRP is preferred when:
- The pathology is tendinopathic or cartilaginous (knee OA, rotator cuff, tennis elbow)
- The injury is acute or subacute
- A growth-factor rich environment is needed to stimulate repair
- The patient wants the most cutting-edge evidence-based option
Prolotherapy is preferred when:
- Ligamentous laxity is the primary finding
- Chronic SI joint or spinal instability is the target
- Cost is a factor and multiple series are appropriate
- As a complementary approach to PRP in complex presentations
Combined protocols are sometimes used — prolotherapy to stabilize lax connective tissue, followed by PRP for active tissue regeneration. We also offer Muse stem cell therapy for patients with advanced tissue damage where growth factor delivery alone may not suffice.
Whatever the approach, all injections at RHPNY are performed under ultrasound guidance for precision and safety.
Book a consultation with Dr. Dhaliwal to evaluate which regenerative injection therapy is appropriate for your condition.
---
Medical Disclaimer: Prolotherapy and PRP therapy are not FDA-approved for all conditions described. Individual results vary. This article is for educational purposes only. Consult a qualified physician before beginning treatment.
